News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
202 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28303)
Month
January (4681)
February (5217)
March (5801)
April (5232)
May (5822)
June (5224)
July (4072)
August (4645)
September (4518)
October (4153)
November (5533)
December (3822)
Day
1 (266)
2 (303)
3 (319)
4 (449)
5 (141)
6 (5)
7 (8)
8 (327)
9 (447)
10 (392)
11 (296)
12 (287)
13 (12)
14 (10)
15 (364)
16 (243)
17 (199)
18 (254)
19 (138)
20 (3)
21 (22)
22 (199)
23 (184)
24 (146)
25 (10)
26 (23)
27 (1)
28 (31)
29 (202)
30 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Genetown
Inhibikase Therapeutics Announces Publication Highlighting Mechanism of Disease and the Potential of Oral c-Abl Kinase Inhibitor Therapy for the Treatment of Parkinson’s Disease
Inhibikase today announced the publication of a paper describing the biochemical rationale and potential benefit of Abelson Tyrosine Kinase (c-Abl) inhibition as a potential disease-modifying therapy for Parkinson’s Disease.
November 29, 2021
·
7 min read
BioMidwest
Riverain Technologies™ will Showcase Enhancements to its AI Platform for Lung Nodule Detection at RSNA
Riverain Technologies™, a leader in artificial intelligence (AI) for early, efficient detection of lung nodules, will showcase its solutions and enhancements at the 107th Annual Radiological Society of North America (RSNA) meeting.
November 29, 2021
·
2 min read
Business
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
ENDRA Life Sciences Inc. announce today the signing of a collaboration agreement to incorporate ENDRA’s proprietary TAEUS technology to support patient screening and biomarker measurement during VGI’s upcoming Phase 2 study of IVB001,
November 29, 2021
·
5 min read
Biotech Bay
Immusoft Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
Funding will Advance Immusoft’s Immune System Programming Platform.
November 29, 2021
·
4 min read
Genetown
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference.
November 29, 2021
·
8 min read
Business
Sesen Bio Strengthens Medical Team
Sesen Bio today announced the strengthening of its medical team with the hiring of Dominika Kowalski as Senior Director of Global Drug Safety.
November 29, 2021
·
7 min read
Deals
Marathon Asset Management Announces Acquisition of Kaléo
Marathon Asset Management Announces Acquisition of Kaléo.
November 29, 2021
·
4 min read
Business
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
Modular Medical, Inc. today announced the expansion of its Board of Directors with the appointment of two independent directors, Steven G. Felsher and Philip B. Sheibley.
November 29, 2021
·
3 min read
Business
Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation
Ranok Therapeutics today announced an agreement with Pfizer Inc. to apply and evaluate Ranok’s CHAMP™ platform technology on an undisclosed cancer target.
November 29, 2021
·
2 min read
Celltrion accelerates development of nebulised cocktail therapy (CT-P63 in combination with CT-P59) using its antibody platform to tackle new COVID-19 variants
Celltrion anticipates CT-P63 to maintain strong neutralising ability against Omicron based on structural analysis by X-ray crystallography and neutralisation data from pseudo-virus testing.
November 29, 2021
·
6 min read
Previous
11 of 21
Next